Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in Switzerland. Swiss Med Wkly [Internet]. 2022 Jun. 20 [cited 2025 Oct. 28];152(2526):w30186. Available from: https://www.smw.ch/index.php/smw/article/view/3221